

The Radiosurgery Society® (RSS) is proud to welcome organizations as Sponsorship Alliance Partners, offering a forum for collaboration on industry standards, scientific methods and clinical advancements in stereotactic radiosurgery, stereotactic body radiotherapy (SRS/SBRT), and advancing therapies.
Our worldwide, multi-disciplinary membership includes clinicians, educators, medical physicists, nurses, administrators, dosimetrists, and allied professionals. Our Sponsorship Alliance Partners help provide opportunities for our members and their institutions, organizations and other like-minded societies to collaborate in an intellectually, scientifically, and technologically rich environment.
Support from our partners allows the RSS to fulfill its mission and, through the unifying efforts of the RSS Sponsorship Alliance, join the ranks of similarly highly-respected institutions, organizations, societies and corporations as champions for developing successful advancements in the field.
The Sponsorship Alliance was introduced in 2012. It continues to expand its global impact and has significantly contributed to the advancement of the RSS mission. Retaining this momentum is critical for the industry, medical community and patients.
The RSS offers three sponsorship opportunities with benefits tailored to each:
We welcome inquiries from organizations interested in joining the RSS as champions for the advancement of the science of SRS/SBRT and advancing therapies. To find out more about joining the RSS Sponsorship Alliance:

Sponsors in this category have contributed to critical advancements in treatment options and patient care, the evolution of safety standards, and contribute to the exchange of knowledge in the field.
Current Sponsors
Benefits include:
"At The James/OSU, we continue to pioneer a number of techniques in the field of stereotactic radiosurgery and stereotactic ablative body radiotherapy, and being an Academic Sponsor allows us the ability both to collaborate with other institutions to continue to advance the field through research endeavors as well as provide education/training based on our robust experience with the goal of improving access to expertly delivered SRS/SABR both nationally and internationally closer to home for patients.” - Raj Singh, M.D., Assistant Professor of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Recognizing that hospitals and practitioners are often affiliated with multiple organizations, the RSS offers a Physicians Group Sponsorship level.
Current Sponsors
Benefits include:
"Asia countries are suffering from the fast-rising cancer incidence and more than 50% of newly diagnosed cancer patients are in Asia. Radiosurgery is not widely available here and the clinical experience of clinicians in radiation field is limited. We are very much honored to be the first physician group sponsor of RSS where we could learn from our experienced colleague and to better serve our patients in Asia. We welcome the RSS members from the world to visit us. - Dr. Qiuxia Lu, Chair of Radiation Oncology, Foshan Chancheng Hospital

The RSS offers unique opportunities for corporate sponsors to demonstrate their sustained commitment to the success of stereotactic radiotherapies while also gaining broad recognition and exposure to the radiation and surgical communities. With a worldwide membership over 700, a presence in 45 countries, and database of over 10,000 domestic and international medical professionals, the RSS offers regular opportunities for you to reinforce your organization’s name recognition and promote the products you manufacture.
Current Sponsors
Benefits include:
"RSS sponsorship enables our ZAP Surgical team to stay in close contact with all of today’s radiosurgical thought leaders while also keeping us informed of the ever changing clinical science landscape. In addition sponsorship provides our company with a fantastic avenue for communicating with RSS members, and in turn supports our clinical development and marketing efforts. It is one of the most forward thinking medical societies of all." - John R. Adler, Jr., MD, CEO Zap Surgical Systems